Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2012 2
2013 1
2014 2
2015 5
2016 4
2017 4
2018 9
2019 15
2020 22
2021 24
2022 25
2023 22
2024 25
2025 34
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
The impact of ERAS protocols on postoperative outcomes in robotic, laparoscopic, and open colorectal surgery: A multicenter retrospective study.
Mohandes B, Abukar SH, Ponholzer F, Öfner D, Enodien B, Ortlieb N, Flaifel M, Frey DM, Vorburger S, Saad B, Müller S, Kollmann C, Kollmann L, Flemming S, Grass JK, Melling N, Rousek M, Abeciūnas V, Poskus T, Bardakcioglu O, Neumann K, Gala-Lopez BL, Honaker MD, Steinemann D, Müller BP, Zeindler J, Kollmar O, Heigl A, Rosenberg R, Taha-Mehlitz S, Taha A. Mohandes B, et al. Am J Surg. 2026 Jan;251:116679. doi: 10.1016/j.amjsurg.2025.116679. Epub 2025 Oct 25. Am J Surg. 2026. PMID: 41207157 Free article.
METHODS: In this multicenter retrospective study, 5503 patients undergoing elective colorectal surgery from 13 centers could be included. Patients were compared regarding surgical technique and ERAS adherence. ...CONCLUSIONS: ERAS protocols improve postoperative out …
METHODS: In this multicenter retrospective study, 5503 patients undergoing elective colorectal surgery from 13 centers could be inclu …
The E-AHPBA-ESSO-Innsbruck consensus recommendations on peri- and postoperative management following liver resection.
Maier E, Stättner S, Carrion-Alvarez L, Di Martino M, Olthof P, Primavesi F, Sochorova D, van Laarhoven S, Balakrishnan A, Breitkopf R, Buis CI, Cipriani F, Erdmann J, Frampton A, Fuks D, Gilg S, Gulla A, Lancellotti F, Margreiter C, Melloul E, Oberkofler C, Petritsch S, Raab H, Rahbari NN, Rappold D, Reiberger T, Ruzzenente A, Sallinen V, Schaefer B, Schnitzbauer AA, Serrablo A, Soreide K, Sparrelid E, Starlinger P, Stavrou GA, Tinguely P, Aldrighetti L, Dasari BVM, Donadon M, Dopazo C, Gruenberger T, Jonas E, Malik H, Viganó L, Siriwardena AK, Maglione M. Maier E, et al. Br J Surg. 2025 Dec 24;113(1):znaf272. doi: 10.1093/bjs/znaf272. Br J Surg. 2025. PMID: 41467576 Free PMC article.
BACKGROUND: Liver surgery carries a high risk of complications due to the complex interplay of patient-related factors, disease characteristics, and liver function. ...CONCLUSION: Optimizing peri- and postoperative care after liver resection remains ch …
BACKGROUND: Liver surgery carries a high risk of complications due to the complex interplay of patient-related factors, diseas …
Oncologic multivisceral resections involving the pancreas.
Rebelo A, Andersson B, Bandyopadhyay SK, Bereza-Carlson P, Berrevoet F, Björnsson B, Bouwense S, Bösch F, Büchler M, Chatzizacharias N, Coubeau L, Crede M, Don CBP, Dries P, Felsenstein M, Frigerio I, Giardino A, Glowka T, Hadesi P, Hartman V, Johansen K, Klein M, Klose J, Knipper K, Leonhardt CS, Loos M, Malinka T, Marchegiani G, Månsson C, Pellegrini R, Perri G, Poelsler L, Roeyen G, Rousek M, Sancho P, Schild-Suhren S, Schmidt T, Serrablo L, Serrablo A, Smith AM, Stavrou GA, Strobel O, Strobel A, Tarantino I, Urdzik J, Vilz T, Vella R, Wennerblom J, Wyzlic P, Kleeff J; Multivisceral Pancreatic Resections Research Group- A Collaboration of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA). Rebelo A, et al. Int J Surg. 2025 Dec 19. doi: 10.1097/JS9.0000000000003731. Online ahead of print. Int J Surg. 2025. PMID: 41417981
Major complications (Clavien-Dindo grade III-V) occurred in 34.4% of patients. Higher ASA classification and open surgical approach were independently associated with increased morbidity and mortality. ...Optimizing patient selection, favoring minimally invasive techniques …
Major complications (Clavien-Dindo grade III-V) occurred in 34.4% of patients. Higher ASA classification and open surgical approach w …
International Benchmark Values for Robotic Right Hepatectomy: Multicenter Study From 22 Expert Centers.
Müller PC, Aegerter NLE, Billeter AT, Eden J, Moeckli B, Lin CC, Abe Y, Nakano Y, Odorizzi R, Sobral M, Primavesi F, Stättner S, Robles-Campos R, Lopez-Lopez V, Guidetti C, Di Benedetto F, Abdelhadi S, Reissfelder C, Araujo RLC, Martinie JB, Memeo R, Delvecchio A, Tschuor C, Fukumori D, D'Hondt M, Wakabayashi T, Wakabayashi G, Lauterio A, Centonze L, Choi GH, Pilz da Cunha G, Swijnenburg RJ, von Kroge P, Heumann A, Katou S, Struecker B, Pascher A, Li Z, Abu Hilal M, El Adel S, Störzer S, Schmelzle M, Mohand JA, Lesurtel M, Drejian S, Fretland ÅA, Edwin B, Ginesini M, Boggi U, Rompianesi G, Troisi RI, Rahimli M, Croner R, Toso C, Kato T, Hawksworth J, Marques HP, Sucandy I, Dutkowski P, Kuemmerli C, Müller BP. Müller PC, et al. Ann Surg Open. 2025 Nov 4;6(4):e625. doi: 10.1097/AS9.0000000000000625. eCollection 2025 Dec. Ann Surg Open. 2025. PMID: 41451175 Free PMC article.
OBJECTIVE: This study aimed to identify benchmark values for robotic right hepatectomy (RH) based on a low-risk cohort treated at expert centers. BACKGROUND: Robotic liver surgery is emerging as a preferred minimally invasive approach to the liver. To enable …
OBJECTIVE: This study aimed to identify benchmark values for robotic right hepatectomy (RH) based on a low-risk cohort treated at expert cen …
Incidence and risk factors for portal vein complications after pediatric liver transplantation: A retrospective cohort analysis from the PORTAL registry.
Alfares BA, Sieben L, Li W, Cervio G, Minetto J, Sierre S, Kaliciński P, Markiewicz-Kijewska M, Kolesnik A, Franchi-Abella S, Gonzales E, Guérin F, Patel JV, Mtegha M, Prasad R, Dierckx RA, de Kleine RH, Kasahara M, Sakamoto S, Uchida H, de Santibañes M, Ardiles V, Uño JW, Marra P, D'Antiga L, Pinelli D, Jaramillo C, Bitterfeld L, Melen A, Wildhaber BE, Beretta M, Aldrian D, Berchtold V, Vogel GF, Hardikar W, Evans H, Duncan D, McCall J, Shah AA, Wood PM, Acord MR, Quintero J, Mercadal-Hally M, Larrarte-King M, Mali V, Aw MM, Hartleif S, Sturm E, Casswall T, Nowak G, Delle M, Khanna R, Pamecha V, Mukund A, Fischer RT, Mullapudi B, Hendrickson RJ, Bokkers RPH, van der Doef HPJ. Alfares BA, et al. Liver Transpl. 2025 Dec 1;31(12):1511-1521. doi: 10.1097/LVT.0000000000000721. Epub 2025 Sep 10. Liver Transpl. 2025. PMID: 40991738
Portal vein complications (PVCs) are recognized but infrequent complications following pediatric liver transplantation (pLT), particularly in young patients with biliary atresia (BA). ...The Portal Vein Obstruction Revascularization Therapy After Liver Tra …
Portal vein complications (PVCs) are recognized but infrequent complications following pediatric liver transplantation (pLT), …
Long-term Outcomes Following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) Versus Pancreatic Ductal Adenocarcinoma (PDAC): A Propensity-score Matched Analysis.
Lucocq J, Halle-Smith J, Haugk B, Joseph N, Hawkyard J, Lye J, Parkinson D, White S, Mownah O, Zen Y, Menon K, Furukawa T, Inoue Y, Hirose Y, Sasahira N, Mittal A, Samra J, Sheen A, Feretis M, Balakrishnan A, Ceresa C, Davidson B, Pande R, Dasari BVM, Tanno L, Karavias D, Helliwell J, Young A, Marks K, Nunes Q, Urbonas T, Silva M, Gordon-Weeks A, Barrie J, Gomez D, van Laarhoven S, Nawara H, Doyle J, Bhogal R, Harrison E, Roalso M, Ciprani D, Aroori S, Ratnayake B, Koea J, Capurso G, Bellotti R, Stättner S, Alsaoudi T, Bhardwaj N, Rajesh S, Jeffery F, Connor S, Cameron A, Jamieson N, Soreide K, Gill AJ, Roberts K, Pandanaboyana S. Lucocq J, et al. Ann Surg. 2025 Dec 1;282(6):1034-1044. doi: 10.1097/SLA.0000000000006272. Epub 2024 Mar 22. Ann Surg. 2025. PMID: 38516777
The E-AHPBA - ESSO - Innsbruck consensus recommendations on peri- and postoperative management following liver resection.
Maier E, Stättner S, Carrion-Alvarez L, Di Martino M, Olthof P, Primavesi F, Socharova D, van Laarhoven S, Balakrishnan A, Breitkopf R, Buis CI, Cipriani F, Erdmann J, Frampton A, Fuks D, Gilg S, Gulla A, Lancellotti F, Margreiter C, Melloul E, Oberkofler C, Petritsch S, Raab H, Rahbari NN, Rappold D, Reiberger T, Ruzzenente A, Sallinen V, Schäfer B, Schnitzbauer AA, Serrablo A, Soreide K, Sparrelid E, Starlinger P, Stavrou GA, Tinguely P, Aldrighetti L, Dasari BVM, Donadon M, Dopazo C, Gruenberger T, Jonas E, Malik H, Viganó L, Siriwardena AK, Maglione M. Maier E, et al. HPB (Oxford). 2025 Nov 13:S1365-182X(25)01671-5. doi: 10.1016/j.hpb.2025.10.008. Online ahead of print. HPB (Oxford). 2025. PMID: 41238460 Free article.
BACKGROUND: Liver surgery carries a high risk of complications due to the interplay of patient-related factors, disease characteristics and liver function. ...Evidence strength varied by topic with lower evidence-levels in complex surgery settings and …
BACKGROUND: Liver surgery carries a high risk of complications due to the interplay of patient-related factors, disease charac …
Diagnostic Accuracy of Imaging in Assessing Nonviability of Disappearing Colorectal Liver Metastasis.
Kataoka K, Mauer M, Shiozawa M, Marreaud S, Kishi Y, Cabrieto J, Onaya H, Ducreux M, Suto T, Kang HC, Matsuhashi N, Fung A, Yasui M, Rivoire M, Tonooka T, Troisi RI, Nakamura K, Stättner S, Kinugasa Y, Foo WC, Desolneux G, Bonhomme B, Ikeda M, Caballero C, Lordick F, Kanemitsu Y, Evrard S. Kataoka K, et al. JAMA Surg. 2025 Nov 1;160(11):1212-1220. doi: 10.1001/jamasurg.2025.3600. JAMA Surg. 2025. PMID: 40960802
IMPORTANCE: In patients with colorectal liver metastases (CLMs), the optimal treatment of disappearing liver metastases (DLMs) diagnosed on postchemotherapy computed tomography (CT) is controversial. ...DESIGN, SETTING, AND PARTICIPANTS: This was a prospective inter …
IMPORTANCE: In patients with colorectal liver metastases (CLMs), the optimal treatment of disappearing liver metastases (DLMs) …
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study.
Moeckli B, Wassmer CH, El Hajji S, Kumar R, Rodrigues Ribeiro J, Tabrizian P, Feng H, Schnickel G, Kulkarni AV, Allaire M, Asthana S, Karvellas CJ, Meeberg G, Wei L, Chouik Y, Kumar P, Gartrell RD, Martinez M, Kang E, Sogbe M, Sangro B, Schwacha-Eipper B, Schmiderer A, Krendl FJ, Goossens N, Lacotte S, Compagnon P, Toso C. Moeckli B, et al. Hepatology. 2025 Nov 1;82(5):1122-1137. doi: 10.1097/HEP.0000000000001289. Epub 2025 Mar 5. Hepatology. 2025. PMID: 40042053 Free article.
BACKGROUND AND AIMS: Immune checkpoint inhibitors (ICIs) are increasingly used in patients with advanced HCC patients awaiting liver transplantation (LT). However, concerns about the risk of posttransplant rejection persist. ...
BACKGROUND AND AIMS: Immune checkpoint inhibitors (ICIs) are increasingly used in patients with advanced HCC patients awaiting liver …
34 results